# Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery

> **NCT03943927** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 107 (actual)

## Conditions studied

- Post-operative Atrial Fibrillation

## Interventions

- **OTHER:** Guided Metoprolol Management

## Key facts

- **NCT ID:** NCT03943927
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-11-20
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2023-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943927, "Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03943927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*